Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Vivien Chan & CoVivien Chan and Anna Mae Koo of Vivien Chan & Co consider the big picture regarding China’s Anti-Unfair Competition Law and explain how its broad application effectively addresses intellectual property infringements -
Sponsored by InspicosA case concerning a payment made after the nine-month opposition period because of a problem with the EPO’s online filing software offers a useful checklist, says Edward Farrington of Inspicos
-
Sponsored by Kangxin PartnersRuixian Liu of Kangxin Partners analyses the key changes under the latest edition of China’s Guidelines for Patent Examination, which particularly concern developments in new fields such as AI and big data
-
Sponsored by Liu, Shen & AssociatesWith the number of Chinese standard-essential patent cases set to increase, Guanyang Yao of Liu Shen & Associates analyses two judgments that are expected to be used as precedents in royalty rate-setting lawsuits
-
Sponsored by Gün and PartnersSelin Sinem Erciyas and Beste Turan of Gün and Partners explain why the World Trade Organization's response to the EU’s claims regarding Chinese preliminary injunction decisions will have a far-reaching impact
-
Sponsored by DEQI Intellectual Property Law CorporationShengjie Piao and Quan Kang of DEQI Intellectual Property Law Corporation provide a summary of the key changes after the introduction of the implementation rules and examination guidelines of China’s revised Patent Law
